NCT00671632 - Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Drug Abuse

Interventions

DRUG

Ramelteon, triazolam, and placebo (56 possible combinations total)

"Randomized sequence over eight consecutive days to include the following:~Ramelteon 16 mg, tablets, orally, one day only;~Ramelteon 80 mg, tablets, orally, one day only;~Ramelteon 160 mg, tablets, orally, one day only;~Triazolam 0.25 mg, capsules, orally, one day only;~Triazolam 0.50 mg, capsules, orally, one day only;~Triazolam 0.75 mg, capsules, orally, one day only;~Ramelteon placebo-matching tablets, orally, one day only, OR Triazolam placebo-matching capsules, orally, one day only;~Additional dose of study medication or placebo, tablets or capsules, orally, one day only."

Trial Locations (1)

Unknown

Baltimore